VRCA

← Markets

VRCAVerrica Pharmaceuticals Inc.

Discussion

Nothing said here yet.

to join the conversation.


Kirby John J.Interim CFO	Buy	5,000	$24.6K	Tue, Aug 18
Rosenberg Noah L.CMO	Buy	2,030	$10.0K	Tue, Aug 18
Zawitz DavidChief Operating Officer	Buy	6,000	$29.9K	Mon, Aug 17
Rieger JaysonCEO and President	Buy	5,000	$24.6K	Mon, Aug 17
Rosenberg Noah L.CMO	Buy	4,200	$20.6K	Mon, Aug 17
Rieger JaysonCEO and President	Buy	20,000	$101.2K	Fri, Aug 14

Kirby John J.Interim CFO

Buy

5,000

$24.6K

Tue, Aug 18

Rosenberg Noah L.CMO

Buy

2,030

$10.0K

Tue, Aug 18

Zawitz DavidChief Operating Officer

Buy

6,000

$29.9K

Mon, Aug 17

Rieger JaysonCEO and President

Buy

5,000

$24.6K

Mon, Aug 17

Rosenberg Noah L.CMO

Buy

4,200

$20.6K

Mon, Aug 17

Rieger JaysonCEO and President

Buy

20,000

$101.2K

Fri, Aug 14

Thu, Aug 27
7:00 AMstocktitan.netVerrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
Fri, Aug 7
2:04 PMmarketbeat.comVerrica Pharmaceuticals Q2 Earnings Call Highlights
Thu, Aug 6
6:10 PMYahooVerrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates
3:05 PMYahooVerrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
3:01 PMYahooVerrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
Thu, Jul 30
7:00 AMYahooVerrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Tue, Jul 21
7:00 AMYahooVerrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
Mon, Jun 22
7:05 AMYahooVerrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
Thu, May 28
7:05 AMYahooVerrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Wed, May 13
7:30 AMmoby.coVerrica Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
7:00 AMYahooVerrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
4:16 AMYahooTranscript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call